Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| MNDR | Mobile-health Network Solutions | $2.20 | -$0.72 | -24.66% | 1.2M | $3.6M | $1.53$40.00 |
| TPST | Tempest Therapeutics | $3.16 | -$1.01 | -24.22% | 444.6K | $18.5M | $3.01$13.65 |
| WTF | Waton Financial | $2.77 | -$0.77 | -21.75% | 213K | $168.4M | $2.71$19.85 |
| ADTX | Aditxt | $2.84 | -$0.73 | -20.45% | 182K | $2.0M | $2.52$11,017.50 |
| SONM | Sonim Technologies | $6.22 | -$1.17 | -15.78% | 87.2K | $7.6M | $5.57$114.84 |
| AMDL | GraniteShares ETF Trust - GraniteShares 2x Long Amd Daily ETF | $13.62 | -$2.46 | -15.30% | 15.2M | - | $2.77$25.86 |
| SUPX | SuperX Ai Technology | $22.09 | -$3.98 | -15.25% | 373.1K | $700.8M | $2.75$76.50 |
| AMUU | Direxion Shares ETF Trust - Direxion Daily Amd Bull 2x Shares | $53.79 | -$9.62 | -15.18% | 6.9K | - | $11.12$101.84 |
| AMDG | Themes ETF Trust - Leverage Shares 2x Long Amd Daily ETF | $25.87 | -$4.50 | -14.81% | 178.8K | - | $5.31$49.00 |
| BDRX | Biodexa Pharmaceuticals Plc | $3.69 | -$0.63 | -14.63% | 35.3K | $2.7M | $3.58$92.00 |
Related Articles
Featured Article
A Quiet AI Stock -- SuperX AI Technology (SUPX) -- Is Up Over 770% in 2025. Here's 1 Key Reason Why It's Getting Attention.
Selena Maranjian|Nov 24, 2025
This company is a very early-stage AI business. It could skyrocket over the coming years, but it might not.
This Undervalued Stock Is Up Over 1,000% This Year. Here's 1 Key Reason Why the Run May Continue
Manali Pradhan, CFA|Nov 9, 2025
Picking a small stake in early stage AI infrastructure players can prove a smart move for investors with above-average risk appetite.
This Small AI Stock Has Outpaced Nvidia. 1 Reason Why It's Still Rising.
Stefon Walters|Oct 22, 2025
This company's path to profitability is getting a lot clearer.
Zhihu IPO: What Investors Should Know About the Quora of China
Lawrence Nga|May 5, 2021
Keep Zhihu on your watchlist. This tech company has the backing of some major Chinese companies.
Don't Get Too Excited About Cambium Networks' Recent IPO
Billy Duberstein|Jul 9, 2019
New IPOs can be exciting, but investors should steer clear of Cambium for now.
